Working… Menu

EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in Japan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01756248
Recruitment Status : Completed
First Posted : December 25, 2012
Last Update Posted : June 25, 2019
Regeneron Pharmaceuticals
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 31, 2018
Actual Study Completion Date : May 20, 2019